Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.

Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G, Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.

J Rheumatol. 2015 Aug 15. pii: jrheum.150185. [Epub ahead of print]

PMID:
26276971
2.

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.

Habets KL, Trouw LA, Levarht EW, Korporaal SJ, Habets PA, de Groot P, Huizinga TW, Toes RE.

Arthritis Res Ther. 2015 Aug 24;17(1):209. doi: 10.1186/s13075-015-0665-7.

3.

Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent.

Verheul MK, Shiozawa K, Levarht EW, Huizinga TW, Toes RE, Trouw LA, Shiozawa S.

Rheumatology (Oxford). 2015 Jul 15. pii: kev250. [Epub ahead of print] No abstract available.

PMID:
26178599
4.

Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.

Janssen KM, de Smit MJ, Brouwer E, de Kok FA, Kraan J, Altenburg J, Verheul MK, Trouw LA, van Winkelhoff AJ, Vissink A, Westra J.

Arthritis Res Ther. 2015 Jul 9;17:174. doi: 10.1186/s13075-015-0690-6.

5.

Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.

van Schaarenburg RA, Schejbel L, Truedsson L, Topaloglu R, Al-Mayouf SM, Riordan A, Simon A, Kallel-Sellami M, Arkwright PD, Åhlin A, Hagelberg S, Nielsen S, Shayesteh A, Morales A, Tam S, Genel F, Berg S, Ketel AG, Merlijn van den Berg J, Kuijpers TW, Olsson RF, Huizinga TW, Lankester AC, Trouw LA.

J Autoimmun. 2015 Aug;62:39-44. doi: 10.1016/j.jaut.2015.06.002. Epub 2015 Jun 26.

PMID:
26119135
6.

Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.

Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, Pahau H, Lee BT, Ng J, G Brunck ME, Hyde C, Trouw LA, Dudek NL, Purcell AW, O'Sullivan BJ, Connolly JE, Paul SK, Lê Cao KA, Thomas R.

Sci Transl Med. 2015 Jun 3;7(290):290ra87. doi: 10.1126/scitranslmed.aaa9301.

PMID:
26041704
7.

C1q, antibodies and anti-C1q autoantibodies.

Beurskens FJ, van Schaarenburg RA, Trouw LA.

Mol Immunol. 2015 May 29. pii: S0161-5890(15)00400-9. doi: 10.1016/j.molimm.2015.05.010. [Epub ahead of print] Review.

PMID:
26032012
8.

Biomarkers for rheumatoid and psoriatic arthritis.

Verheul MK, Fearon U, Trouw LA, Veale DJ.

Clin Immunol. 2015 Apr 28. pii: S1521-6616(15)00135-7. doi: 10.1016/j.clim.2015.04.005. [Epub ahead of print]

PMID:
25934385
9.

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.

Brink M, Verheul MK, Rönnelid J, Berglin E, Holmdahl R, Toes RE, Klareskog L, Trouw LA, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2015 Feb 7;17:25. doi: 10.1186/s13075-015-0536-2.

10.

Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system.

Stoop JN, Fischer A, Hayer S, Hegen M, Huizinga TW, Steiner G, Trouw LA, Toes RE.

Ann Rheum Dis. 2015 May;74(5):949-50. doi: 10.1136/annrheumdis-2014-206797. Epub 2015 Feb 4. No abstract available.

PMID:
25653200
11.

Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.

Gan RW, Trouw LA, Shi J, Toes RE, Huizinga TW, Demoruelle MK, Kolfenbach JR, Zerbe GO, Deane KD, Edison JD, Gilliland WR, Norris JM, Holers VM.

J Rheumatol. 2015 Apr;42(4):572-9. doi: 10.3899/jrheum.140767. Epub 2015 Jan 15.

PMID:
25593232
12.

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Rombouts Y, Willemze A, van Beers JJ, Shi J, Kerkman PF, van Toorn L, Janssen GM, Zaldumbide A, Hoeben RC, Pruijn GJ, Deelder AM, Wolbink G, Rispens T, van Veelen PA, Huizinga TW, Wuhrer M, Trouw LA, Scherer HU, Toes RE.

Ann Rheum Dis. 2015 Jan 13. pii: annrheumdis-2014-206598. doi: 10.1136/annrheumdis-2014-206598. [Epub ahead of print]

PMID:
25587188
13.

Complement activation in Glioblastoma multiforme pathophysiology: evidence from serum levels and presence of complement activation products in tumor tissue.

Bouwens TA, Trouw LA, Veerhuis R, Dirven CM, Lamfers ML, Al-Khawaja H.

J Neuroimmunol. 2015 Jan 15;278:271-6. doi: 10.1016/j.jneuroim.2014.11.016. Epub 2014 Nov 18.

14.

Five decades of Dutch immunology.

Germeraad WT, de Jong EC, Trouw LA.

Immunol Lett. 2014 Dec;162(2 Pt B):83-4. doi: 10.1016/j.imlet.2014.10.006. Epub 2014 Oct 18. No abstract available.

PMID:
25455593
15.

Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.

van Schaarenburg RA, Daha NA, Schonkeren JJ, Nivine Levarht EW, van Gijlswijk-Janssen DJ, Kurreeman FA, Roos A, van Kooten C, Koelman CA, Ernst-Kruis MR, Toes RE, Huizinga TW, Lankester AC, Trouw LA.

Immunobiology. 2015 Mar;220(3):422-7. doi: 10.1016/j.imbio.2014.10.005. Epub 2014 Oct 18.

PMID:
25454803
16.

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.

Stoop JN, Liu BS, Shi J, Jansen DT, Hegen M, Huizinga TW, Trouw LA, Toes RE.

PLoS One. 2014 Jul 15;9(7):e102163. doi: 10.1371/journal.pone.0102163. eCollection 2014.

17.

Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.

Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.

Ann Rheum Dis. 2014 Oct;73(10):1761-8. doi: 10.1136/annrheumdis-2013-205109. Epub 2014 May 8.

PMID:
24812286
18.

Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Gelderman KA, Drop AC, Trouw LA, Bontkes HJ, Bouma G, van Hoogstraten IM, von Blomberg BM.

Clin Exp Immunol. 2014 Jul;177(1):86-93. doi: 10.1111/cei.12302.

19.

Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.

Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Hamann D, van Schaardenburg D, Toes RE, Trouw LA.

Ann Rheum Dis. 2014 Apr;73(4):780-3. doi: 10.1136/annrheumdis-2013-204154. Epub 2013 Dec 13.

PMID:
24336334
20.

Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.

Shi J, van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, Huizinga TW, Toes RE, Trouw LA.

Autoimmun Rev. 2014 Mar;13(3):225-30. doi: 10.1016/j.autrev.2013.10.008. Epub 2013 Oct 28. Review.

PMID:
24176675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk